OXYBUTYNIN IN TREATMENT OF HYPERACTIVE URINARY BLADDER IN CHILDREN

Abstract

This article describes an experience of treatment of children (n=92) with miction disorders – syndrome of hyperactive urinary bladder (HUB) with oxybutynin (Driptane). Treatment resulted in decrease of median grade of disorder of urination from 12.5 marks initially to 5.2 marks after 4 weeks of treatment. This effect remained during 3 following months. Besides, the frequency of urinations was lessened in 23%, urgent feeling of urination – in 46%, urgent incontinence was stopped completely. Symptoms of enuresis were more resistant to treatment, and they were stopped completely in 6 children. Side effects, concerned with therapy, were registered in 3 (3%) children. Thus, oxybutynin in effective and safe medication for treatment of children with urinary disorders – HUB syndrome.Key words: children, syndrome of hyperactive urinary bladder, treatment, oxybutynin.(Voprosy sovremennoi pediatrii — Current Pediatrics. 2009;8(1):104-107)